A phase II study of a temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424.

Barbara Jean Fisher, Jeff Lui, David R. Macdonald, Glenn Jay Lesser, Stephen Coons, David Brachman, Samuel Ryu, Maria Werner-Wasik, Jean-Paul Bahary, Chen Hu, Minesh P. Mehta

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
StatePublished - Jan 30 2017

Disciplines

  • Medicine and Health Sciences
  • Surgery
  • Immunology and Infectious Disease
  • Other Medical Specialties

Cite this